Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1957 4
1959 1
1960 2
1961 3
1962 2
1963 1
1964 4
1965 4
1966 4
1967 5
1968 6
1969 3
1970 2
1971 7
1972 1
1974 7
1975 2
1976 4
1979 2
1980 3
1981 4
1982 1
1984 2
1985 3
1986 1
1988 3
1992 1
1994 2
1995 1
1996 2
1997 6
1999 7
2000 12
2001 8
2002 7
2003 4
2004 7
2005 5
2006 6
2007 11
2008 13
2009 21
2010 28
2011 14
2012 9
2013 11
2014 11
2015 13
2016 18
2017 23
2018 17
2019 15
2020 20
2021 11
2022 23
2023 18
2024 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

407 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for takacs i
Search for Tacacs I instead (1 results)
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.
Sacher A, LoRusso P, Patel MR, Miller WH Jr, Garralda E, Forster MD, Santoro A, Falcon A, Kim TW, Paz-Ares L, Bowyer S, de Miguel M, Han SW, Krebs MG, Lee JS, Cheng ML, Arbour K, Massarelli E, Choi Y, Shi Z, Mandlekar S, Lin MT, Royer-Joo S, Chang J, Dharia NV, Schutzman JL, Desai J; GO42144 Investigator and Study Group. Sacher A, et al. N Engl J Med. 2023 Aug 24;389(8):710-721. doi: 10.1056/NEJMoa2303810. N Engl J Med. 2023. PMID: 37611121 Free article. Clinical Trial.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
A debreceni mellkassebészet: múlt és jelen.
Takács I, Enyedi A, Váradi C, Kóder G, Mudriczki G, Tóth D. Takács I, et al. Magy Seb. 2022 Mar 24;75(1):67-74. doi: 10.1556/1046.2021.10014. Print 2022 Mar 24. Magy Seb. 2022. PMID: 35333768 No abstract available.
[Sepsis-associated encephalopathy].
Szatmári S, Végh T, Antek C, Takács I, Síró P, Fülesdi B. Szatmári S, et al. Among authors: takacs i. Orv Hetil. 2010 Aug 15;151(33):1340-6. doi: 10.1556/OH.2010.28932. Orv Hetil. 2010. PMID: 20693145 Review. Hungarian.
Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis.
Lawitz EJ, Fraessdorf M, Neff GW, Schattenberg JM, Noureddin M, Alkhouri N, Schmid B, Andrews CP, Takács I, Hussain SA, Fenske WK, Gane EJ, Hosseini-Tabatabaei A, Sanyal AJ, Mazo DF, Younes R; NCT05296733 Investigators. Lawitz EJ, et al. Among authors: takacs i. J Hepatol. 2024 Nov;81(5):837-846. doi: 10.1016/j.jhep.2024.06.003. Epub 2024 Jun 8. J Hepatol. 2024. PMID: 38857788 Free article. Clinical Trial.
Intravascular B-cell lymphoma.
Erös N, Károlyi Z, Kovács A, Takács I, Radványi G, Kelényi G. Erös N, et al. Among authors: takacs i. J Am Acad Dermatol. 2002 Nov;47(5 Suppl):S260-2. doi: 10.1067/mjd.2002.108493. J Am Acad Dermatol. 2002. PMID: 12399744 Review.
407 results